TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, neoplasm, squamous cell carcinoma, squamous cell neoplasm	Recruiting	Not applicable	2024-07-26		NCT04481256

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	199
Catharina Ziekenhuis Eindhoven	45
Deventer Ziekenhuis	10
Elisabeth-TweeSteden Ziekenhuis	14
Erasmus Medical Center	271
Frisius Medisch Centrum	12
Institute Verbeeten	3
Isala	30
Leiden University Medical Center	183
Radiotherapeutic Institute Friesland	2
Radiotherapy Group Deventer	1
Rijnstate Hospital	42
The Netherlands Cancer Institute	113
UMC Utrecht	140
University Medical Center Groningen	213
Ziekenhuisgroep Twente	10

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Academic Medical Center, Medical Oncology	Amsterdam	Netherlands	4